Advertisement

Topics

Osiris Therapeutics Company Profile

00:37 EST 23rd November 2017 | BioPortfolio

Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues. The next revolution in medical care Osiris Therapeutics is commercializing products from a readily available and non-controversial source – adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissue and offer a very real opportunity to develop revolutionary new treatments for certain disease processes including autoimmune disorders, heart attacks and arthritis. Osiris’ technology is based on the pioneering work of Dr. Arnold Caplan and his colleagues at Case Western Reserve University. They showed that Mesenchymal Stem Cells (MSCs) can engraft and selectively differentiate, based on the tissue environment, to such lineages as muscle, bone, cartilage, marrow stroma, tendon and fat. Due to their cellular origin and phenotype, these cells do not provoke an immune response, allowing for the development of products derived from unrelated human donors.

Location

2001 Aliceanna Street
Baltimore
MD
21231
United States of America

Contact

Phone: 410 522 5005
Fax: 410 522 6999
Email: osiris@Osiris.com


News Articles [552 Associated News Articles listed on BioPortfolio]

Osiris Therapeutics Appoints Linda Palczuk As President And CEO

WASHINGTON (dpa-AFX) - Osiris Therapeutics Inc. announced that it appointed Linda Palczuk, age 55, to serve as President and CEO, effective July 10, 2017. She will stand for election to the Board ...

Osiris Pays $1.5M Penalty, Settles SEC Charges over Accounting Practices

Osiris Therapeutics has agreed to pay a $1.5 million civil penalty and settle charges by the U.S. Securities and Exchange Commission (SEC) that the company, its ex-CEO and three other former executive...

Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation

COLUMBIA, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the “Company”), a leading regenerative medicine company focused on developing and marketing product...

Osiris Therapeutics, Inc. Provides Update on Audit of 2015 and 2016 Financial Statements

COLUMBIA, Md., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the “Company”), a leading regenerative medicine company focused on developing and marketing product...

Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology

COLUMBIA, Md., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...

Former CFO Pleads Guilty To Lying To Auditors

Former Osiris Therapeutics, Inc. CFO Philip Jacoby pleaded guilty to criminal charges stemming from the financial fraud at the company. U.S. v.

Osiris Names Former AstraZeneca PLC Exec as New CEO

  Life Sciences Jobs   ...

Osiris Therapeutics Inc OSIR Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryOsiris Therapeutics Inc Osiris is a biotechnology company that conducts research, development and commercialization of stem cell products for the treatment of conditions related to wound, ortho...

Clinical Trials [123 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1169 Associated Companies listed on BioPortfolio]

Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc. is the leading stem cell therapeutic company focused on developing products to treat serious medical conditions in the inflammatory, autoimmune, orthoped...

Osiris Therapeutics

Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair...

Spencer Trask

Spencer Trask develops innovative ideas into world-changing companies. The company is the legacy of Mr. Spencer Trask, the financier who backed Thomas Edison and invested in the light bulb, the first...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Osiris Therapeutics" on BioPortfolio

We have published hundreds of Osiris Therapeutics news stories on BioPortfolio along with dozens of Osiris Therapeutics Clinical Trials and PubMed Articles about Osiris Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Osiris Therapeutics Companies in our database. You can also find out about relevant Osiris Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record